论文部分内容阅读
目的观察糖皮质激素(辅舒酮)吸入治疗小儿哮喘的临床疗效。方法轻、中度哮喘患儿61例,临床缓解后进入为期12周的缓解期治疗。将缓解治疗患儿随即分为两组,辅舒酮气雾剂125μg/次,1次/d(A组);125μg/次,2次/d(B组)。分别于第4、8、12周调查临床疗效,同时进行日间、夜间评分,并于第12周末对其疗效进行分析。结果接受辅舒酮治疗并成功随访的有61例,12周结束时两组临床疗效指标比较差异经卡方检验差异具有统计学意义。结论辅舒酮125μg/次,2次/d,可有效控制轻、中度哮喘。
Objective To observe the clinical efficacy of glucocorticoid (Fuk ketone) inhalation in the treatment of pediatric asthma. Methods 61 cases of mild and moderate asthma children, clinical remission after entering a 12-week remission treatment. The patients were divided into two groups: Fufukon aerosol 125μg / time, once a day (group A), 125μg / time, twice a day (group B). At the 4th, 8th and 12th week respectively, the clinical efficacy was investigated, and the daytime and nighttime scores were also scored. The curative effect was analyzed on the 12th week. Results 61 cases were treated with fu-qin-ket and successfully followed up. After 12 weeks, the differences of clinical curative effect between the two groups were statistically significant by chi-square test. Conclusions Fuxuetong 125μg / time, 2 times / d, can effectively control mild to moderate asthma.